← Back to Search

Platelet-rich Plasma

Injection into olfactory cleft for Phantosmia

N/A
Waitlist Available
Led By Zara M. Patel, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months

Summary

This trial will test whether an injection of platelet-rich plasma can improve the sense of smell in patients with reduced function.

Eligible Conditions
  • Phantosmia
  • Anomia
  • Olfactory Nerve Disorder
  • Coronavirus
  • Olfactory Nerve Injury
  • Olfactory Nerve Disease
  • Olfactory Disorders
  • Post-Viral Syndrome
  • Loss of Smell or Anosmia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smelling ability

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet Rich PlasmaExperimental Treatment1 Intervention
Injection of 1cc patient's own platelet rich plasma (PRP) into olfactory cleft x4
Group II: SalinePlacebo Group1 Intervention
Injection of 1cc saline into olfactory cleft x4
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Injection into olfactory cleft
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of California, San DiegoOTHER
1,180 Previous Clinical Trials
1,575,017 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,475 Previous Clinical Trials
17,501,453 Total Patients Enrolled
Zara M. Patel, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
40 Total Patients Enrolled
~7 spots leftby Nov 2025